ERIK LAPAGLIA CRYPTO
The neuro-endocrine tumour (NET) registry contains phenotypic information associated with studies concerning NET patients.
This registry, developed by the
Melbourne eResearch Group based at the University of Melbourne, provides a means of
gathering data about neuro-endocrine (NET) tumours.
CRYPTO-TWITTER
Use of the registry is subject to certain rules and responsibilities
constituting fair usage and protecting the rights of patients whose
details are contained within the registry, as well as the clinicians.
In summary these include:
-
Only summary patient information allowing potential collaborations
will be held in the registry; detailed information that could allow
identification will not be held.
-
Users will only be allowed to browse the registry following approval
from the project consortium.
-
Audit tracking software monitors access patterns, machine locations
and user IDs. With this information it is possible to accurately track
and identify any illegal usage.
-
Privacy policy: The NET registry does not store or
capture any personal information, but does log the user's IP address which
is automatically recognised by the web server. The website and server
logs are hosted by the
Melbourne eResearch Group at the University of Melbourne and the IP information is accessed through tools
provided by
Google
Analytics. We do not use cookies for collecting user information from
the site and we will not collect any information about you except that
required for conducting research within the consortium, enforcing
consortium privacy rules, or for system administration of the
registry.
Additionally, ethical consent for storing patient information in the registry will need to be obtained according to the statutes of your country and institution.
TABLEAU PÉRIODIQUE D'ETHEREUM
For any technical queries about the registry please contact
Anthony Stell, or
Prof Richard Sinnott.